Escherichia coli is a frequent cause of life-threatening bloodstream infections [1] and other common infections, such as urinary tract infections. Antibiotic resistance rates in E. coli are rapidly rising, especially with regard to fluoroquinolones and third- and fourth-generation cephalosporins. Surprisingly, most of these multidrug-resistant strains are acquired in the community rather than in healthcare settings [2, 3].